Pharmaceutical R&D expenditure by therapeutic area Worldwide 2015

This statistic presents the share of pharmaceutical R&D expenditure worldwide in 2015, by therapeutic area. R&D expenditure on anti-cancer and immunomodulators accounts for 28 percent, R&D expenditure on alimentary and metabolism accounts for 10.4 percent.

Share of pharmaceutical research and development expenditure Worldwide in 2015, by therapeutic area

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

December 2016

Region

Worldwide

Survey time period

2015

Supplementary notes

* Other category includes: blood, genitourinary and sex hormones, hormones (exc. sex hormones and insulin), dermatologicals, sensory and non TA specific.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical market worldwide"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.